I'll explore data-related challenges, the increasing importance of a robust data strategy and considerations for businesses ...

SageX is an AI-native enterprise data platform designed to transform unstructured and multimodal data into governed, machine-readable, workflow-ready information. By continuously refining, validating, ...

Chromosomes are masters of organization. These long strings of DNA fold down into an ensemble of compact structures that keep needed parts of the genome accessible while tucking away those that aren't ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...

Condensed-matter physics and materials science have a silo problem. Although researchers in these fields have access to vast amounts of data – from experimental records of crystal structures and ...

Structure Therapeutics’ lead drug candidate is chasing big pharmaceutical rivals in the race for new oral weight-loss medications, and the company had been telling investors to expect data late this ...

Eli Lilly is casting a long shadow over the GLP-1 market. Structure Therapeutics linked its oral candidate to significant reductions in blood sugar and weight in a phase 2a trial on Monday, only for ...